DDX31 |
Q9H8H2
|
DEAD-box helicase 31
|
|
2.0E-12 |
0.780 |
0.115 |
FAAH2 |
Q6GMR7
|
fatty acid amide hydrolase 2
|
Enzyme
|
1.9E-21 |
0.821 |
0.115 |
SCUBE3 |
Q8IX30
|
signal peptide, CUB domain and EGF like domain containing 3
|
Extracellular structure
|
1.00 |
0.839 |
0.115 |
FILNC1 |
|
FOXO induced long non-coding RNA 1
|
|
|
0.861 |
0.115 |
YIPF3 |
Q9GZM5
|
Yip1 domain family member 3
|
|
0.14 |
0.821 |
0.115 |
OR4C13 |
Q8NGP0
|
olfactory receptor family 4 subfamily C member 13
|
G-protein coupled receptor
|
2.5E-10 |
0.821 |
0.115 |
VMO1 |
Q7Z5L0
|
vitelline membrane outer layer 1 homolog
|
|
2.1E-06 |
0.821 |
0.115 |
MSGN1 |
A6NI15
|
mesogenin 1
|
|
7.2E-02 |
0.821 |
0.115 |
SLC35G2 |
Q8TBE7
|
solute carrier family 35 member G2
|
Transporter
|
4.0E-02 |
0.890 |
0.115 |
FPGT |
O14772
|
fucose-1-phosphate guanylyltransferase
|
|
1.1E-10 |
0.821 |
0.115 |
ZNF765 |
Q7L2R6
|
zinc finger protein 765
|
|
8.7E-06 |
0.821 |
0.115 |
AP1M2 |
Q9Y6Q5
|
adaptor related protein complex 1 subunit mu 2
|
Extracellular structure
|
2.1E-08 |
0.931 |
0.115 |
C4orf46 |
Q504U0
|
chromosome 4 open reading frame 46
|
|
4.0E-02 |
0.861 |
0.115 |
TMIGD1 |
Q6UXZ0
|
transmembrane and immunoglobulin domain containing 1
|
|
2.1E-07 |
0.861 |
0.115 |
MAGEA9 |
P43362
|
MAGE family member A9
|
Cell adhesion
|
|
0.861 |
0.115 |
LOC100507703 |
|
HLA class I histocompatibility antigen, A-69 alpha chain-like
|
|
|
0.890 |
0.115 |
MYO7B |
Q6PIF6
|
myosin VIIB
|
Cellular structure
|
9.0E-31 |
1.000 |
0.115 |
KCNQ1DN |
Q9H478
|
KCNQ1 downstream neighbor
|
|
|
0.931 |
0.115 |
PNRC2 |
Q9NPJ4
|
proline rich nuclear receptor coactivator 2
|
|
0.34 |
0.890 |
0.115 |
COPS7B |
Q9H9Q2
|
COP9 signalosome subunit 7B
|
|
0.60 |
0.931 |
0.115 |
HAUS8 |
Q9BT25
|
HAUS augmin like complex subunit 8
|
|
1.5E-06 |
1.000 |
0.115 |
TRIM52-AS1 |
|
TRIM52 antisense RNA 1 (head to head)
|
|
|
0.931 |
0.115 |
MAGEA9B |
P43362
|
MAGE family member A9B
|
|
|
0.931 |
0.115 |
UBAC2-AS1 |
|
UBAC2 antisense RNA 1
|
|
|
0.931 |
0.115 |
LNCSRLR |
|
lncRNA sorafenib resistance in renal cell carcinoma associated
|
|
|
0.931 |
0.115 |